Mr. Hoffman has over 30 years of professional investment experience as both a capital allocator and direct investor. As the former Chief Investment Officer at Mayo Clinic for over 25 years, he developed Mayo’s global multi-asset investment strategy and helped Mayo achieve top tier long term performance. He also co-founded Mayo’s in-house venture co-investment program which has grown significantly. In addition, Harry served as Treasurer for Mayo and oversaw issuance of debt and banking, insurance and risk management relationships. Robert Luo, HMVP’s founder and CEO, worked under Mr. Hoffman before leaving Mayo Clinic to found HM Healthcare Management Services and HM Venture Partners.

Mr. Hoffman is Co-Founder and Co-Manager of Southeast Minnesota Capital Partners, which manages two seed and early-stage venture capital funds that back high potential Minnesota medtech and life sciences start-ups, including many with Mayo Clinic roots. The Funds’ investors include many Mayo Clinic physicians and business leaders as well as high net worth individuals and investment professionals from across the U.S.

Mr. Hoffman currently sits on the boards of several SMCF portfolio companies and is an investment advisor to a large family office. Previously, he served on the boards of Latigo Petroleum, Okabena Company, the Rochester Economic Development Agency, the Ronald McDonald House of Rochester, The Investment Fund for Foundations (TIFF), and the Endowment Board of the American Red Cross.

Mr. Hoffman received his BA degree from the University of Minnesota and his MBA from the Yale School of Management.

Mr. Herbert has over 30 years of leadership experience in the life sciences sector, spanning start-ups, strategic collaborations, international operations, and venture investing.

Over a 21-year career at Mayo Clinic, Mr. Herbert served as Chief Administrative Officer of Mayo Clinic Laboratories, one of the largest specialty medical reference laboratories in the world, serving clients in over 100 countries. In addition, he led the New Ventures and Technology Commercialization divisions at Mayo Clinic Ventures and later served as Chair of Mayo Clinic Global Business Solutions, charged with extending Mayo Clinic products and services globally.

Mr. Herbert is Co-Founder and Co-Manager of Southeast Minnesota Capital Partners, which manages two seed and early-stage venture funds that back high potential Minnesota medtech and life sciences start-ups, including many with Mayo Clinic roots. The Funds’ investors include many Mayo Clinic physicians and business leaders as well as high net worth individuals and investment professionals from across the U.S.

Since 2015, Mr. Herbert has served on the board and as Treasurer of the Myotonic Dystrophy Foundation, the world’s largest patient organization focused solely on myotonic dystrophy. Since 2014, David has been the Head Coach of the Rochester Nordic Ski Team, which coaches ski technique and racing for an all-city cross country ski team with over 107 athletes and 30 coaches.

Mr. Herbert holds a BA from Stanford University and an MBA from the University of St. Thomas.

Dr. Wang has more than 25 years of technical, business development, sales & marketing, and executive management experience in Biotech and Pharmaceutical industries in the U.S., Asia, and other regions. He joined HM Venture Partners as a general partner in 2024.

Dr. Wang has been the CEO of two Biotech companies and a leading CDMO company, as well as other executive leader for major CRO companies in drug discovery. He has led organizations achieve high growth and raised over $100M capital to propel the growth of startups. He is well-versed in advanced therapeutics field and has overseen operations with global footprints and complex organizational structures. Through continued emphasis on scientific understandings, Dr. Wang is keen to identify and cultivate entrepreneurs and breakthrough technologies that can transform medicine and improve cancer care.

Dr. Wang received his PhD of Cellular Molecular Biology from Roswell Park Cancer Cancer/SUNY Buffalo and M. Eng. of Computer Sciences from Univ. of Colorado at Boulder. He was also an assistant professor at the Dept. of Structural Biology Department at Hauptman-Woodward Medical Institute, University of Buffalo School of Medicine.